Current Cancer Drug Targets

Papers
(The H4-Index of Current Cancer Drug Targets is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Old and New Approaches to Target the Hsp90 Chaperone104
Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation86
Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer77
COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide31
The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance23
Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy20
CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis20
Nanotechnology-enabled Chemodynamic Therapy and Immunotherapy20
The Therapeutic Potential of MAPK/ERK Inhibitors in the Treatment of Colorectal Cancer20
Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy20
Protectors of the Mitochondrial Permeability Transition Pore Activated by Iron and Doxorubicin18
Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks16
C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors15
Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors15
Targeting IDH Mutations in AML: Wielding the Double-edged Sword of Differentiation14
MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy14
Exosome as a Natural Gene Delivery Vector for Cancer Treatment14
The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer14
0.058089971542358